流通市值:11.72亿 | 总市值:25.78亿 | ||
流通股本:3864.10万 | 总股本:8502.80万 |
报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
公司类型 | 通用 | 通用 | 通用 | 通用 |
流动资产: | ||||
货币资金 | 194,334,754.22 | 258,319,534.07 | 388,787,616.84 | 381,907,767.59 |
结算备付金 | 0 | - | 0 | 0 |
拆出资金 | 0 | - | 0 | 0 |
衍生金融资产 | 0 | 34,840 | 0 | 0 |
应收票据及应收账款 | 472,163,937.84 | 419,347,531.01 | 363,522,180.98 | 396,871,929.1 |
其中:应收票据 | 91,746,441.11 | 77,641,176.82 | 81,759,899.88 | 83,103,705.12 |
应收账款 | 380,417,496.73 | 341,706,354.19 | 281,762,281.1 | 313,768,223.98 |
应收款项融资 | 24,865,884.66 | 9,281,572.42 | 44,956,402.49 | 29,844,921.41 |
预付款项 | 3,896,504.05 | 4,057,332.41 | 4,169,633.84 | 4,318,141.23 |
应收保费 | 0 | - | 0 | 0 |
应收分保账款 | 0 | - | 0 | 0 |
应收分保合同准备金 | 0 | - | 0 | 0 |
其他应收款合计 | 4,052,782.61 | 4,367,736.02 | 5,597,741.95 | 2,814,562.35 |
其中:应收利息 | 0 | - | 0 | 0 |
应收股利 | 0 | - | 0 | 0 |
买入返售金融资产 | 0 | - | 0 | 0 |
存货 | 112,787,151.92 | 106,202,194.61 | 69,960,605.93 | 72,209,916.36 |
合同资产 | 0 | - | 0 | 0 |
一年内到期的非流动资产 | 0 | - | 0 | 0 |
其他流动资产 | 8,076,996.96 | 9,014,333.84 | 5,397,195.16 | 6,585,111.98 |
流动资产平衡项目 | 0 | 0 | 0 | 0 |
流动资产合计 | 1,216,579,694.45 | 1,163,514,538.08 | 1,212,639,035.92 | 1,202,895,923.15 |
非流动资产: | ||||
发放委托贷款及垫款 | 0 | - | 0 | 0 |
债权投资 | 0 | - | 0 | 0 |
其他债权投资 | 0 | - | 0 | 0 |
长期应收款 | 0 | - | 0 | 0 |
长期股权投资 | 0 | - | 0 | 0 |
其他权益工具投资 | 0 | - | 0 | 0 |
其他非流动金融资产 | 0 | - | 0 | 0 |
投资性房地产 | 16,505,117.93 | 16,100,997.37 | 16,229,918.65 | 16,358,839.93 |
固定资产 | 55,061,220.43 | 55,597,648.86 | 47,104,038.34 | 47,280,573.3 |
在建工程 | 0 | - | 474,398.87 | 143,564.36 |
生产性生物资产 | 0 | - | 0 | 0 |
油气资产 | 0 | - | 0 | 0 |
使用权资产 | 2,747,450.48 | 823,795.27 | 841,608.34 | 992,557.96 |
无形资产 | 19,885,708.17 | 5,916,679.51 | 5,998,795.48 | 6,102,702.34 |
开发支出 | 0 | - | 0 | 0 |
商誉 | 264,082.8 | 264,082.8 | 264,082.8 | 264,082.8 |
长期待摊费用 | 9,348,918.58 | 2,254,250.9 | 2,022,251.12 | 2,220,854.17 |
递延所得税资产 | 5,356,445.25 | 5,036,645.82 | 5,268,936.39 | 4,855,080.67 |
其他非流动资产 | 3,725,933.21 | 5,623,637.03 | 2,900,000 | 3,176,000 |
非流动资产平衡项目 | 0 | 0 | 0 | 0 |
非流动资产合计 | 112,894,876.85 | 91,617,737.56 | 81,104,029.99 | 81,394,255.53 |
资产平衡项目 | 0 | 0 | 0 | 0 |
资产总计 | 1,329,474,571.3 | 1,255,132,275.64 | 1,293,743,065.91 | 1,284,290,178.68 |
流动负债: | ||||
短期借款 | 0 | - | 0 | 0 |
向中央银行借款 | 0 | - | 0 | 0 |
吸收存款及同业存放 | 0 | - | 0 | 0 |
拆入资金 | 0 | - | 0 | 0 |
交易性金融负债 | 0 | - | 0 | 0 |
衍生金融负债 | 0 | - | 0 | 0 |
应付票据及应付账款 | 124,550,735.61 | 83,688,707.62 | 69,058,708.29 | 70,403,499.56 |
其中:应付票据 | 70,645,435.3 | 28,760,139.3 | 26,348,968.58 | 32,348,968.58 |
应付账款 | 53,905,300.31 | 54,928,568.32 | 42,709,739.71 | 38,054,530.98 |
预收款项 | 0 | - | 0 | 0 |
合同负债 | 4,001,061.39 | 4,177,719.57 | 2,986,755.64 | 1,719,014.25 |
卖出回购金融资产款 | 0 | - | 0 | 0 |
应付手续费及佣金 | 0 | - | 0 | 0 |
应付职工薪酬 | 10,212,500.93 | 9,176,344.29 | 8,664,159.57 | 13,425,023.26 |
应交税费 | 7,621,510.37 | 4,131,129.71 | 8,862,592.48 | 7,489,741.79 |
其他应付款合计 | 4,461,480.67 | 2,131,325.7 | 1,957,035.63 | 2,046,914.16 |
其中:应付利息 | 0 | - | 0 | 0 |
应付股利 | 0 | - | 0 | 0 |
应付分保账款 | 0 | - | 0 | 0 |
保险合同准备金 | 0 | - | 0 | 0 |
代理买卖证券款 | 0 | - | 0 | 0 |
代理承销证券款 | 0 | - | 0 | 0 |
一年内到期的非流动负债 | 1,173,521.41 | 473,198.09 | 468,184.47 | 501,959.44 |
其他流动负债 | 46,043,223.28 | 45,456,595.15 | 42,887,572.34 | 50,226,782.53 |
流动负债平衡项目 | 0 | 0 | 0 | 0 |
流动负债合计 | 198,064,033.66 | 149,235,020.13 | 134,885,008.42 | 145,812,934.99 |
非流动负债: | ||||
长期借款 | 0 | - | 0 | 0 |
应付债券 | 0 | - | 0 | 0 |
优先股 | 0 | - | 0 | 0 |
永续债 | 0 | - | 0 | 0 |
租赁负债 | 1,489,582.09 | 336,376.07 | 369,217.3 | 485,774.97 |
长期应付款 | 0 | - | 0 | 0 |
长期应付职工薪酬 | 0 | - | 0 | 0 |
预计负债 | 0 | - | 0 | 0 |
递延收益 | 2,132,577.41 | 2,870,871.96 | 2,083,739.2 | 2,311,449.55 |
递延所得税负债 | 664,212.57 | 181,037.67 | 193,580.19 | 225,626.04 |
其他非流动负债 | 0 | - | 0 | 0 |
非流动负债平衡项目 | 0 | 0 | 0 | 0 |
非流动负债合计 | 4,286,372.07 | 3,388,285.7 | 2,646,536.69 | 3,022,850.56 |
负债平衡项目 | 0 | 0 | 0 | 0 |
负债合计 | 202,350,405.73 | 152,623,305.83 | 137,531,545.11 | 148,835,785.55 |
所有者权益(或股东权益): | ||||
实收资本(或股本) | 85,028,000 | 85,028,000 | 58,640,000 | 58,640,000 |
其他权益工具 | 0 | - | 0 | 0 |
优先股 | 0 | - | 0 | 0 |
永续债 | 0 | - | 0 | 0 |
资本公积 | 647,946,531.32 | 647,121,916.81 | 672,948,917.25 | 672,948,917.25 |
减:库存股 | 0 | - | 0 | 0 |
其他综合收益 | -27,536.34 | 26,070.6 | 0 | 812,345 |
专项储备 | 5,080,497.87 | 4,819,297.34 | 4,887,226.68 | 4,928,069.11 |
盈余公积 | 29,320,000 | 29,320,000 | 29,320,000 | 29,320,000 |
一般风险准备 | 0 | - | 0 | 0 |
未分配利润 | 359,776,672.72 | 336,193,685.06 | 390,415,376.87 | 368,805,061.77 |
归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
归属于母公司股东权益合计 | 1,127,124,165.57 | 1,102,508,969.81 | 1,156,211,520.8 | 1,135,454,393.13 |
少数股东权益 | 0 | - | 0 | 0 |
股东权益平衡项目 | 0 | 0 | 0 | 0 |
股东权益合计 | 1,127,124,165.57 | 1,102,508,969.81 | 1,156,211,520.8 | 1,135,454,393.13 |
负债和股东权益合计 | 1,329,474,571.3 | 1,255,132,275.64 | 1,293,743,065.91 | 1,284,290,178.68 |
公告日期 | 2024-10-29 | 2024-08-29 | 2024-04-23 | 2024-04-23 |
审计意见(境内) | 标准无保留意见 |